# Precision-T (NCT05316701)

> Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

No report yet. It can be ordered.

- Drugs tested: Orca-T
- Indication: advanced hematologic malignancies

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT05316701
- Phase: PHASE3
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Orca Biosystems, Inc.
- Conditions: Acute Myeloid Leukemia; Acute Lymphoid Leukemia; Mixed Phenotype Acute Leukemia; Undifferentiated Leukemia; Myelodysplastic Syndrome; Acute Leukemia; Therapy-Related Myelodysplastic Syndrome
- Interventions: Orca-T; Standard-of-Care
- Enrollment: 187
- Primary outcome: Event-free at 12 Months for Moderate or Severe Chronic Graft-versus-Host-Disease-free Survival (cGFS) Per Endpoint Adjudication Committee (EAC)

## Indexed commentary on Precision-T so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 14
- YouTube: 13
- Podcasts: 12
- Bluesky threads: 4

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=precision-t-nct05316701

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT05316701", "email": "<work email>"}; the inbox owner confirms by the emailed link.